EE200200511A - Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks - Google Patents
Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviksInfo
- Publication number
- EE200200511A EE200200511A EEP200200511A EEP200200511A EE200200511A EE 200200511 A EE200200511 A EE 200200511A EE P200200511 A EEP200200511 A EE P200200511A EE P200200511 A EEP200200511 A EE P200200511A EE 200200511 A EE200200511 A EE 200200511A
- Authority
- EE
- Estonia
- Prior art keywords
- hydroxyphenylpiperazinylmethylbenzamide
- pain
- derivatives
- treatment
- hydroxyphenylpiperazinylmethylbenzamide derivatives
- Prior art date
Links
- SSWJFHVTNOQNFQ-UHFFFAOYSA-N C1CN(CCN1)CC2=C(C=CC(=C2C3=CC=CC=C3)O)C(=O)N Chemical class C1CN(CCN1)CC2=C(C=CC(=C2C3=CC=CC=C3)O)C(=O)N SSWJFHVTNOQNFQ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0001209A SE0001209D0 (sv) | 2000-04-04 | 2000-04-04 | Novel compounds |
| PCT/SE2001/000709 WO2001074805A1 (en) | 2000-04-04 | 2001-03-30 | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200511A true EE200200511A (et) | 2004-02-16 |
Family
ID=20279148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200511A EE200200511A (et) | 2000-04-04 | 2001-03-30 | Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6696447B2 (enExample) |
| EP (1) | EP1278740B1 (enExample) |
| JP (1) | JP2003529597A (enExample) |
| KR (1) | KR20020084284A (enExample) |
| CN (1) | CN1422266A (enExample) |
| AR (1) | AR033811A1 (enExample) |
| AT (1) | ATE297914T1 (enExample) |
| AU (1) | AU2001244983A1 (enExample) |
| BR (1) | BR0109818A (enExample) |
| CA (1) | CA2402705A1 (enExample) |
| CZ (1) | CZ20023287A3 (enExample) |
| DE (1) | DE60111520T2 (enExample) |
| EE (1) | EE200200511A (enExample) |
| HU (1) | HUP0300562A3 (enExample) |
| IL (1) | IL151765A0 (enExample) |
| IS (1) | IS6563A (enExample) |
| MX (1) | MXPA02009758A (enExample) |
| NO (1) | NO20024776L (enExample) |
| NZ (1) | NZ521388A (enExample) |
| PL (1) | PL357812A1 (enExample) |
| SE (1) | SE0001209D0 (enExample) |
| SK (1) | SK14262002A3 (enExample) |
| WO (1) | WO2001074805A1 (enExample) |
| ZA (1) | ZA200207381B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9504661D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| SE0100764D0 (sv) | 2001-03-07 | 2001-03-07 | Astrazeneca Ab | New assymetric process |
| ES2319876T3 (es) * | 2001-05-18 | 2009-05-14 | Astrazeneca Ab | Derivados de 4 (fenil-piperazinil-metil) benzamida y su uso para el tratamiento de la ansiedad o trastornos gastrointestinales. |
| TW200301701A (en) | 2002-01-02 | 2003-07-16 | Ardent Pharmaceuticals Inc | Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| US8476280B2 (en) | 2002-05-09 | 2013-07-02 | Versi Group, Llc | Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| SE0203300D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203302D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203303D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0400027D0 (sv) * | 2004-01-09 | 2004-01-09 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| SE0401968D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| DK1781631T3 (da) * | 2004-08-02 | 2012-05-14 | Astrazeneca Ab | Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf |
| CN101128447A (zh) * | 2005-02-28 | 2008-02-20 | 阿斯利康(瑞典)有限公司 | 二芳基甲基哌嗪衍生物，其制备及其用途 |
| US20090291966A1 (en) * | 2008-05-20 | 2009-11-26 | Astrazeneca Ab | Method Of Treating Anxious Major Depressive Disorder |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH585209A5 (enExample) | 1973-06-29 | 1977-02-28 | Cermol Sa | |
| DE2900810A1 (de) | 1979-01-11 | 1980-07-24 | Cassella Ag | Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung |
| IT1140978B (it) | 1980-05-23 | 1986-10-10 | Selvi & C Spa | 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche |
| GB8320701D0 (en) | 1983-08-01 | 1983-09-01 | Wellcome Found | Chemotherapeutic agent |
| IT1196150B (it) | 1984-06-19 | 1988-11-10 | Poli Ind Chimica Spa | Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono |
| SE8500573D0 (sv) | 1985-02-08 | 1985-02-08 | Ferrosan Ab | Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain |
| US5028610A (en) | 1987-03-18 | 1991-07-02 | Sankyo Company Limited | N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use |
| US4829065A (en) | 1987-04-24 | 1989-05-09 | Syntex Pharmaceuticals, Ltd. | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives |
| US4826844A (en) | 1987-09-30 | 1989-05-02 | American Home Products Corporation | Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols |
| DE69033926T2 (de) | 1989-11-22 | 2002-10-24 | Janssen Pharmaceutica N.V., Beerse | Verwendung von Piperazin-Acetamid-Derivaten gegen Reperfusionsschaden |
| US5807858A (en) | 1996-06-05 | 1998-09-15 | Delta Pharmaceutical, Inc. | Compositions and methods for reducing respiratory depression |
| US5574159A (en) | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
| US5681830A (en) | 1992-02-03 | 1997-10-28 | Delta Pharmaceuticals, Inc. | Opioid compounds |
| GB9202238D0 (en) | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| FR2696744B1 (fr) | 1992-10-12 | 1994-12-30 | Logeais Labor Jacques | Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique. |
| DK0711289T3 (da) | 1993-07-30 | 2000-11-06 | Delta Pharmaceuticals Inc | Piperazinforbindelser til anvendelse i terapi |
| JP3352184B2 (ja) | 1993-11-12 | 2002-12-03 | 株式会社アズウェル | ピペラジン不飽和脂肪酸誘導体 |
| SE9504661D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
| SE9604786D0 (sv) | 1996-12-20 | 1996-12-20 | Astra Pharma Inc | New compounds |
| JP4754068B2 (ja) * | 1997-12-24 | 2011-08-24 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | δ−オピオイドレセプターに結合する４−［アリール（ピペリジン−４−イル）］アミノベンズアミド類 |
| GB9804734D0 (en) * | 1998-03-05 | 1998-04-29 | Pfizer Ltd | Compounds |
-
2000
- 2000-04-04 SE SE0001209A patent/SE0001209D0/xx unknown
-
2001
- 2001-03-28 AR ARP010101479A patent/AR033811A1/es not_active Application Discontinuation
- 2001-03-30 CA CA002402705A patent/CA2402705A1/en not_active Abandoned
- 2001-03-30 NZ NZ521388A patent/NZ521388A/en not_active Application Discontinuation
- 2001-03-30 BR BR0109818-7A patent/BR0109818A/pt not_active IP Right Cessation
- 2001-03-30 IL IL15176501A patent/IL151765A0/xx unknown
- 2001-03-30 CZ CZ20023287A patent/CZ20023287A3/cs unknown
- 2001-03-30 EP EP01918115A patent/EP1278740B1/en not_active Expired - Lifetime
- 2001-03-30 PL PL01357812A patent/PL357812A1/xx not_active Application Discontinuation
- 2001-03-30 AT AT01918115T patent/ATE297914T1/de not_active IP Right Cessation
- 2001-03-30 HU HU0300562A patent/HUP0300562A3/hu unknown
- 2001-03-30 DE DE60111520T patent/DE60111520T2/de not_active Expired - Fee Related
- 2001-03-30 US US10/240,037 patent/US6696447B2/en not_active Expired - Fee Related
- 2001-03-30 SK SK1426-2002A patent/SK14262002A3/sk not_active Application Discontinuation
- 2001-03-30 CN CN01807719A patent/CN1422266A/zh active Pending
- 2001-03-30 MX MXPA02009758A patent/MXPA02009758A/es unknown
- 2001-03-30 KR KR1020027013206A patent/KR20020084284A/ko not_active Withdrawn
- 2001-03-30 JP JP2001572495A patent/JP2003529597A/ja active Pending
- 2001-03-30 AU AU2001244983A patent/AU2001244983A1/en not_active Abandoned
- 2001-03-30 WO PCT/SE2001/000709 patent/WO2001074805A1/en not_active Ceased
- 2001-03-30 EE EEP200200511A patent/EE200200511A/xx unknown
-
2002
- 2002-09-13 ZA ZA200207381A patent/ZA200207381B/en unknown
- 2002-09-24 IS IS6563A patent/IS6563A/is unknown
- 2002-10-03 NO NO20024776A patent/NO20024776L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20020084284A (ko) | 2002-11-04 |
| BR0109818A (pt) | 2003-01-21 |
| DE60111520D1 (de) | 2005-07-21 |
| SK14262002A3 (sk) | 2003-05-02 |
| HUP0300562A3 (en) | 2006-02-28 |
| MXPA02009758A (es) | 2003-03-27 |
| CN1422266A (zh) | 2003-06-04 |
| EP1278740A1 (en) | 2003-01-29 |
| WO2001074805A1 (en) | 2001-10-11 |
| IL151765A0 (en) | 2003-04-10 |
| PL357812A1 (en) | 2004-07-26 |
| DE60111520T2 (de) | 2006-05-11 |
| AU2001244983A1 (en) | 2001-10-15 |
| NO20024776L (no) | 2002-12-03 |
| SE0001209D0 (sv) | 2000-04-04 |
| NO20024776D0 (no) | 2002-10-03 |
| NZ521388A (en) | 2004-06-25 |
| ZA200207381B (en) | 2003-12-15 |
| IS6563A (is) | 2002-09-24 |
| JP2003529597A (ja) | 2003-10-07 |
| US20030139421A1 (en) | 2003-07-24 |
| HUP0300562A2 (hu) | 2003-08-28 |
| ATE297914T1 (de) | 2005-07-15 |
| CZ20023287A3 (cs) | 2003-03-12 |
| US6696447B2 (en) | 2004-02-24 |
| AR033811A1 (es) | 2004-01-07 |
| CA2402705A1 (en) | 2001-10-11 |
| EP1278740B1 (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200200571A (et) | Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks | |
| DK1267650T3 (da) | Tobakbehandling | |
| NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
| EE200200673A (et) | Kinasoliini derivaadid kasvajate raviks | |
| EE200200145A (et) | Retigabiini kasutamine neuropaatilise valu raviks | |
| NO20014379D0 (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
| FI20000863A0 (fi) | Uusi hoitomenetelmä | |
| DK1176964T3 (da) | Brug af ET743 til behandling af cancer | |
| NO20032122L (no) | Forbedret behandling | |
| EE200200577A (et) | Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks | |
| EE200200511A (et) | Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks | |
| NO20026219L (no) | Forbindelser for behandling av svekket fundisk relaksasjon | |
| IS6626A (is) | Kristallskenndur meðferðarmiðill | |
| DK1286986T3 (da) | Quinolinylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerte | |
| FI20002756A0 (fi) | Uusi hoitomenetelmä | |
| SE9903421D0 (sv) | Behandlingsförfarande | |
| NO20032885D0 (no) | Elektrodebehandling | |
| SI1282616T1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain | |
| ITMI20000147A0 (it) | Procedimeto per il trattamento di fanghi | |
| NO20011189L (no) | Innretning for behandling av suspensjoner |